Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
China Traditional Chinese Medicine Holdings Co ( (HK:0570) ) has provided an announcement.
China Traditional Chinese Medicine Holdings Co. Limited reported a decline in revenue and profit for the first half of 2025, with total revenue dropping by 11% and a net loss of RMB 141.76 million compared to a profit in the previous year. The decrease in revenue was observed across most product lines, with the most significant drop in the Chinese medicinal herbs integration business. This downturn reflects challenges in the TCM market and may impact the company’s strategic positioning and stakeholder relations.
The most recent analyst rating on (HK:0570) stock is a Hold with a HK$2.50 price target. To see the full list of analyst forecasts on China Traditional Chinese Medicine Holdings Co stock, see the HK:0570 Stock Forecast page.
More about China Traditional Chinese Medicine Holdings Co
China Traditional Chinese Medicine Holdings Co. Limited operates in the traditional Chinese medicine industry, focusing on products such as concentrated TCM granules, finished drugs, decoction pieces, and medicinal herbs. The company is integrated into the broader TCM health sector.
Average Trading Volume: 30,756,384
Technical Sentiment Signal: Sell
Current Market Cap: HK$11.03B
For detailed information about 0570 stock, go to TipRanks’ Stock Analysis page.